Clinical Trials Browser

Terminated × INDUSTRY × tamibarotene × Clear all

NCT04905407 2025-02-24

Tamibarotene Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Phase 2 Terminated

66 enrolled 21 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01337154 2013-06-28

First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung